Holen Sie sich die Stockscreener-App
3.11
4.01%
-0.13
Handel nachbörslich:
3.16
0.05
+1.61%
Lixte Biotechnology Holdings Inc Aktie (LIXT) Neueste Nachrichten
Lixte Amends Share Exchange, Clarifies Liora Ownership Structure - TipRanks
Lixte Biotechnology Enters Amended Share Exchange to Consolidate Liora Ownership With Orbit Capital - TradingView
LIXTE Biotechnology Holdings (LIXT) Adds Innovative LiGHT Therapy to Pipeline - Yahoo Finance
LIXTE Biotechnology (LIXT) Advances Lead Compound in Tumor Immunogenicity Research - NewMediaWire
LIXTE Biotechnology (NASDAQ: LIXT) Advances Lead Compound in Tumor Immunogenicity Research - TradingView
Powell Max Limited Successfully Repositions for Its Next Phase of Growth - The Manila Times
Aug Sectors: Whats the profit margin of Lixte Biotechnology Holdings IncWeekly Profit Recap & Capital Efficient Trading Techniques - baoquankhu1.vn
Trade Report: What is the next catalyst for Lixte Biotechnology Holdings Inc Equity WarrantWeekly Gains Summary & Technical Entry and Exit Alerts - baoquankhu1.vn
Volatility Watch: What is the next catalyst for Lixte Biotechnology Holdings Inc Equity WarrantWeekly Stock Summary & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Why Lixte Biotechnology Holdings Inc. stock attracts high net worth investorsMarket Risk Analysis & Safe Entry Point Alerts - Naître et grandir
Wall Street Recap: Why is Lixte Biotechnology Holdings Inc Equity Warrant stock going downDollar Strength & Risk Controlled Daily Plans - baoquankhu1.vn
MACD Signal: How does Lixte Biotechnology Holdings Inc Equity Warrant perform in inflationary periodsTrade Analysis Report & Low Risk Growth Stock Ideas - baoquankhu1.vn
LIXTW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
LIXTE Biotechnology (NASDAQ: LIXT) Appoints Sidney Braun as CEO of Liora Technologies Europe Subsidiary - Digital Journal
LIXTE Biotechnology (NASDAQ: LIXT) Aligns Liora and LiGHT System With LB-100 to Push Frontier of Cancer Treatment - Digital Journal
Downgrade Watch: Will Lixte Biotechnology Holdings Inc stock go up in YEARJuly 2025 Summary & Precise Entry and Exit Recommendations - baoquankhu1.vn
Should I Buy LIXT? LIXT 2026 AnalysisIntellectia AI™ - Intellectia AI
LIXTWLixte Biotechnology Hldgs Inc Latest Stock News & Market Updates - Stock Titan
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Sponsors Good Health Mind, Body and Soul Summit - USA Today
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK - USA Today
Should I invest in Lixte Biotechnology Holdings Inc. before earningsJuly 2025 Chart Watch & Expert Approved Trade Ideas - mfd.ru
Is Lixte Biotechnology Holdings Inc. stock a value trap2025 Stock Rankings & Accurate Entry and Exit Point Alerts - mfd.ru
Why Lixte Biotechnology Holdings Inc. stock could rally in 2025July 2025 WrapUp & Precise Swing Trade Alerts - mfd.ru
What is the next catalyst for Lixte Biotechnology Holdings Inc. Equity WarrantWeekly Loss Report & Verified Trade Idea Suggestions - mfd.ru
Will Lixte Biotechnology Holdings Inc. stock go up in YEARJuly 2025 Summary & Community Verified Trade Signals - mfd.ru
LIXTE Biotechnology appoints Sidney Braun to lead Liora subsidiary By Investing.com - Investing.com India
LIXTE Biotechnology (LIXT) Appoints Sidney Braun as CEO of Liora Technologies Europe Subsidiary - NewMediaWire
Lixte Elevates Liora Leadership to Advance Proton Therapy - TipRanks
LIXTE Biotechnology appoints Sidney Braun to lead Liora subsidiary - Investing.com
Lixte Biotechnology appoints Sidney Braun as CEO, Liora - TipRanks
LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary - GlobeNewswire
LIXTE Biotechnology Appoints Sidney Braun as CEO of Its Liora Technologies Europe Ltd. Subsidiary - 富途牛牛
Growth Review: Is Cognyte Software Ltd stock a smart retirement pickMarket Risk Summary & Real-Time Volume Surge Alerts - baoquankhu1.vn
How does Lixte Biotechnology Holdings Inc. Equity Warrant perform in inflationary periodsJuly 2025 Setups & Free Daily Entry Point Trade Alerts - mfd.ru
Why is Lixte Biotechnology Holdings Inc. stock going down2025 Pullback Review & Fast Entry Momentum Alerts - mfd.ru
LIXTE Biotechnology (LIXT) Bringing First-in-Class Approach to Chemo and Immunotherapy - NewMediaWire
LIXTE Biotechnology (NASDAQ: LIXT) Bringing First-in-Class Approach to Chemo and Immunotherapy - Digital Journal
Can Lixte Biotechnology Holdings Inc. Equity Warrant be recession proofTrade Ideas & Short-Term High Return Strategies - mfd.ru
How is Lixte Biotechnology Holdings Inc. managing supply chain issuesWeekly Trade Recap & Capital Protection Trading Alerts - mfd.ru
How Lixte Biotechnology Holdings Inc. Equity Warrant stock trades during market volatilityJuly 2025 Levels & Daily Entry Point Trade Alerts - mfd.ru
How Lixte Biotechnology Holdings Inc. Equity Warrant stock compares to growth peersWeekly Profit Report & AI Driven Stock Price Forecasts - mfd.ru
LIXTE Biotechnology (LIXT) Aligns Liora and LiGHT System With LB-100 to Push Frontier of Cancer Treatment - NewMediaWire
LIXTE Biotechnology (LIXT) Positions LB-100 to Expand Effectiveness of Standard Cancer Treatment - Yahoo Finance
LIXTE Biotechnology (NASDAQ: LIXT) Positions LB-100 to Expand Effectiveness of Standard Cancer Treatment - Digital Journal
Earnings Miss: Will Lixte Biotechnology Holdings Inc Equity Warrant stock benefit from M AMarket Activity Report & High Accuracy Investment Entry Signals - baoquankhu1.vn
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):